491 studies found for:    Wilson Disease
Show Display Options
Rank Status Study
21 Unknown  Interstitial Lung Disease Questionnaire
Condition: Interstitial Lung Disease
22 Completed
Has Results
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Conditions: Adenocarcinoma of the Colon;   Stage III Colon Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Biological: cetuximab;   Drug: Locally Directed Therapy
23 Not yet recruiting Putting CDSMP to Work
Conditions: Chronic Disease;   Cardiovascular Diseases
Interventions: Behavioral: Workplace-tailored CDSMP;   Behavioral: Chronic Disease Self-Management Program
24 Active, not recruiting Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Condition: Hyperphosphatemia
25 Not yet recruiting RCT of Bibliotherapy for Social Anxiety Disorder as a Prelude to CBT in IAPT
Conditions: Bibliotherapy;   Social Anxiety Disorder;   Cognitive Behavioral Therapy
Interventions: Procedure: Cognitive-Behavioural Bibliotherapy;   Procedure: Cognitive-Behavioural Therapy;   Other: WAIT
26 Recruiting Therapeutic Use of Ultrasound in Acute Coronary Artery Disease
Condition: Acute Myocardial Infarction
Interventions: Procedure: Therapeutic ultrasound with 20 usec;   Procedure: Repeated diagnostic high mechanical index
27 Terminated
Has Results
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: thalidomide;   Radiation: radiation therapy
28 Active, not recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Condition: Arthritis, Rheumatoid
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
29 Active, not recruiting
Has Results
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Doxorubicin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: Dacarbazine;   Drug: Vincristine;   Drug: Mechlorethamine;   Drug: Etoposide;   Drug: Prednisone;   Drug: Cyclophosphamide;   Radiation: Radiotherapy
30 Active, not recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Conditions: Colon Mucinous Adenocarcinoma;   Colon Signet Ring Cell Adenocarcinoma;   Lynch Syndrome;   Stage IIA Colon Cancer;   Stage IIB Colon Cancer;   Stage IIC Colon Cancer
Interventions: Biological: Bevacizumab;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin
31 Completed Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance
Conditions: Alcoholism;   Stress Disorders, Post-Traumatic
Interventions: Behavioral: Experiential acceptance;   Behavioral: Cognitive restructuring;   Other: No-intervention control: Nutrition information
32 Active, not recruiting
Has Results
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Chronic Phase of Disease
Interventions: Drug: Dasatinib;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis
33 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
34 Completed Dialysis Clinical Outcomes Revisited (DCOR) Trial
Condition: Chronic Kidney Disease
Interventions: Drug: Sevelamer hydrochloride;   Drug: Calcium-based phosphate binder
35 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate
36 Recruiting Adjuvant Sequential Intravesical BCG (Bacillus Calmette-Guérin) and Electromotive Mitomycin-C (EMDA/MMC) After Transuretheral Resection (TUR) in Patients With Primary High Risk Non-Muscle Invasive Transitional Cell Carcinoma of the Bladder. A One-group Phase II Study.
Condition: Bladder Carcinoma
Intervention: Device: Intravesical instillation of sequential Bacillus Calmette-Guérin (BCG) and Electromotive Drug Administration /Mitomycin-C
37 Recruiting Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
Conditions: Recurrent Plasma Cell Myeloma;   Refractory Plasma Cell Myeloma
Interventions: Drug: Carfilzomib;   Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis
38 Recruiting Lung-MAP: S1400 Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IIIB-IV Squamous Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Biological: anti-B7H1 monoclonal antibody MEDI4736;   Drug: PI3 kinase inhibitor GDC-0032;   Drug: palbociclib isethionate;   Drug: FGFR inhibitor AZD4547;   Biological: rilotumumab;   Drug: docetaxel;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
39 Active, not recruiting
Has Results
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Radiation: Standard fractionation RT;   Radiation: Accelerated fractionation radiation therapy;   Procedure: Conventional surgery for select patients
40 Recruiting Treatment and Natural History Study of Lymphomatoid Granulomatosis
Conditions: Lymphomatoid Granulomatosis;   Granulomatosis, Lymphomatoid;   Non-Hodgkins Lymphoma;   Lymphoproliferative Disorder
Interventions: Biological: Interferon;   Drug: Rituxan and EPOCH

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years